| 今开：0.436 | 昨收：0.436 |
| 最高：0.43989 | 最低：0.385 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5268390.0 |
Seelos Therapeutics(SEEL)2021-01-16 05:21
$Seelos Therapeutics(SEEL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-21-010077 Act: 34 Size: 38 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-12 19:42
$Seelos Therapeutics(SEEL)$ 8-K Current report, item 8.01 Accession Number: 0001136261-21-000007 Act: 34 Size: 9 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-09 05:36
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-21-000003 Size: 5 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-09 05:42
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-21-000002 Size: 5 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-12 05:06
$Seelos Therapeutics(SEEL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-21-000037 Act: 34 Size: 65 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-09 05:42
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-21-000001 Size: 5 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2021-01-09 05:36
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001136261-21-000004 Size: 5 KB 网页链接查看全文
Seelos Therapeutics(SEEL)2019-11-08 13:20
$Seelos Therapeutics(SEEL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001136261-19-000264 Size: 3 MB 网页链接查看全文
产业链观察03-20 00:37
#药闻简讯# $Seelos Therapeutics(SEEL)$ SLS-005（静脉注射海藻糖）的肌萎缩侧索硬化症 （ALS） 研究 - 在主要和次要终点中未达到统计学意义。#临床研究失败#查看全文
美股滚雪球2023-06-25 14:45
psychedelic stocks：$COMPASS Pathways(CMPS)$ 、$Mind Medicine(MNMD)$ 、$Seelos Therapeutics(SEEL)$ 、$Bright Minds(DRUG)、$180 Life(ATNF)、$GH Research(GHRS)查看全文
令狐不冲9992021-09-29 21:12
9.29盘前异动：$BriaCell(BCTX)$ $Seelos Therapeutics(SEEL)$ $ProQR Therapeutics(PRQR)$查看全文
产业链观察2021-05-28 20:52
药闻| 2021年5月27日，专注于为治疗中枢神经系统疾病和罕见疾病的发展的临床阶段的生物制药公司$Seelos Therapeutics(SEEL)$ 今天宣布SLS-005（海藻糖）获得欧盟的孤儿药资格，用于治疗肌萎缩性侧索硬化症。查看全文
牛唐2021-05-18 10:34
医药板块速评（2021.0517）
本期内容提示：
1、此前推的逆向并购概念股$Aerpio制药(ARPO)$ 宣布了并购，后续是否还有行情？哪些标的还有类似的潜力？
2、又一双抗药物平台获得多家机构建仓，是否有投资机会？
3、$Seelos Therapeutics(SEEL)$ 数据不错，缘何大跌，是否有抄底机会...查看全文
Seelos Therapeutics盘前跌4.25%，报0.153美元。消息上，在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后，Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”，同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-040106 Act: 34 Size: 226 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-036125 Act: 34 Size: 2 MB 网页链接
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000670 Act: 33 Size: 1 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-035009 Act: 33 Size: 574 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-031558 Act: 33 Size: 102 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-031555 Act: 33 Size: 803 KB 网页链接
$Seelos Therapeutics(SEEL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000140 Act: 34 Size: 9 MB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030070 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-24-023870 Act: 33 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000387 Act: 34 Size: 81 KB 网页链接